DRUG STUDY

Name of the Patient: Mrs. B Age: 68 y/o Sex: F Name of Student: PENGSON,ANGELA N.
Civil Status: Single Religion: ______________Rm/Bed No. _________________ Area: __________________________ Level/ Block: III-B
Address: _________________________________________________________________ Date Submitted: SEPTEMBER 23,2022
Date of Admission: _____________________ Diagnosis: hypokalemia Rating: ___________________________________________________

Drug Name/Dosage/
Classification/ Contraindication Side Effects
Route/Frequency/ Drug Indication Adverse Reactions Nursing Considerations
Mechanism of Action
Order
Generic Name: Therapeutic effect: ● Treatment Hypersensitivity to ● Peripheral Before:
● Metronidazole ● Produce of metronidazole Frequent: neuropathy
s anaerobic (manifested as ● Follow the 10
Anorexia,
Brand name bacterici infections. Rights of Drug
nausea, dry numbness, Administration.
● Flagyl dal, Also, it is tingling of
mouth, metallic
antiprot frequently
taste hands/feet) ● Check and verify
Usual Route ozoal, used to
usually is the doctor’s order.
● PO, IV amoebic treat
idal, gastrointes Occasional: reversible
● Assess and monitor
Usual Dosage: trichom tinal Diarrhea, the vital signs of
● ADULTS, onacidal infections ● If treatment is the patient.
constipation,
ELDERLY: 500 mg effects. as well as stopped
vomiting,
q6–8h. trichomoni immediately upon ● Review the
asis and dizziness, patient’s history
appearance of
Drug order: PHARMACOT giardiasis, erythematous neurologic and check for
Metronidazole 500mg HERAPEUTIC: and rash, urticaria, allergies and
symptoms contraindications
through intravenous fluid ● Nitroimida amebiasis reddish-brown
every 6 hours, ● Seizures occur with the
zole which are urine. occasionally medication.
derivative parasitic
infections. ● Perform proper
Action Rare:
Mild, transient handwashing.
● Diffuses
into leukopenia;
 organism, thrombophlebiti ● Perform skin
interacting s with IV testing.
with DNA therapy
causing a ● Explain why the
loss of medication is given
helical and why is it
necessary.
DNA
structure ● Obtain baseline
and strand CBC, LFT.
breakage,
inhibiting ● Obtain specimens
protein for diagnostic tests,
synthesis. cultures before
giving first dose
Pharma (therapy may begin
cokineti before results are
cs: known).

Absorp During
tion: ● Verify the patient’s
name.
Well
absorbe ● Follow the
d from directions on the
GI tract; medicine label.
minimal
ly ● Position patient
absorbe appropriately
d after formedication
topical administration.
applicati
on ● Ensure proper body
mechanics for the
Protein healthcare
binding providers
:
less than ● Administer
20% Metronidazole
500mg through
Distrib intravenous fluid
every 6 hours
ution:
Widely After:
distribut ● Monitor daily
ed; pattern of bowel
crosses activity, stool
blood- consistency.
brain
barrier. ● Monitor I&O

Metabo ● Assess for urinary

lism: problems. Be alert
Metabol to neurologic
ized in symptoms
(dizziness,
liver
paresthesia of
extremities).
Excreti
on: ● Assess for rash,
Excrete urticaria
d in
urine ● Educate the patient
(80%), to avoid tasks that
feces require alertness,
(15%). motor skills until
Remove response to drug is
d by established.
 hemodia
lysis. ● Document all the
relevant
PHAR information such as
MACO name of the drug,
DYNA dosage and time it
MICS: was given. Also,
the patient
condition.
Onset:
Rapid

Peak:
End of
infusion

Duratio
n:
6-8 h

Half-
life:
8 hrs
Drug Name/Dosage/ Classification/
Contraindication Side Effects Adverse
Route/Frequency/ Drug Mechanism of Indication Nursing Considerations
Reactions
Order Action
Generic Name: Classification ● Treatment ● Conditions Occasional: CNS: BEFORE
● Potassium ● Thera and in which Nausea, confusion, unusual fatigue, ● Check and
chloride peutic prevention potassium vomiting, restlessness, asthenia, verify
(Kalium : of retention flaccid paralysis, doctor’s order
Durules) diarrhea,
Preven hypokalemi is present. paresthesia, absent reflexes regarding the
ts a. Solid oral flatulence, medication.
Brand name: dosage abdominal
motion CV: ● Observe 10
Dextrose and - form in pts discomfort with ECG changes, hypotension, rights: Right
Electrolyte No. 75 induce in whom distention arrhythmias, heart block, patient, drug,
d there is cardiac arrest dose, time, and
Usual Route nausea structural, route.
Rare:
● P.O /vomit pathologic GI: ● Make a
Rash medication card
ing cause for nausea, vomiting, diarrhea,
Drug order: ● Phar delay in with the
abdominal discomfort,
● Kalium Durules macol passage complete doctor’s
flatulence
750mg one tablet per ogic: through GI order, name of the
orem BID Electr tract. patient, bed
Metabolic: number and
olyte hyperkalemia
Usual dosage/ room/ward
frequency: ● Obtain and
Action Musculoskeletal:
Severe: record vital
● Maintains weakness and heaviness of
Initially, 40 mEq given 3–4 signs.
acid-base
times/day. (May also give legs ● Secure a copy of
balance,
20 mEq q2–3h in the client’s health
isotonicity,
conjunction with careful Respiratory: history for
and
monitoring.) respiratory contraindications
electrophys
paralysis and drug
iologic
interactions
balance
(notify the
throughout
physician if any).
body
● Ask the client’s
tissues.
full name to
Clinical: verify his
● Potassium identity.
replenisher Educate and explain
the medication to the
PHARMACOKIN client, how it works,
ETICS why it is given to
Absorption: him, and the possible
 ● Well side effects
absorbed
from GI DURING
tract ● Follow the
directions on the
Protein binding medicine label.
● NotAvailab ● Position patient
le appropriately for
medication
Distribution: administration.
● Enters cells
● Ensure proper
by active
body mechanics
transport
from for the
extracellular healthcare
fluid. providers
● Administer
Metabolism: Metoclopramide
● NotAvailabl one tablet every
e 8 hours PRN for
Excretion:
vomiting.
Excreted in urine

PHARMACODYN AFTER:
AMICS: ● Monitor serum
Onset: potassium,
Unknown calcium, Phosphate

Peak: ● Be alert to
1-2 hr evidence of
hyperkalemia
Duration (skin
Unknown pallor/coldness,
paresthesia,
Half-life: feeling of
not available heaviness of
lower
extremities).

● Educate the
patient to eat
foods rich in
potassium (beef,
ham, chicken,
fish, milk,
bananas)

● Advise to report
numbness,
feeling of
heaviness of
lower
extremities,
weakness,
unusual fatigue.

● Document all
the relevant
information such
as name of the
drug, dosage,
 and time it was
given. Also, the
patient
condition.

Drug Name/Dosage/ Classification/

Route/Frequency/ Drug Mechanism of Indication Contrain Side Effects Adverse Reactions Nursing Considerations
Order Action dication
Generic Name It is used in ● Hypersen Frequent: ● Extrapyramidal BEFORE
● Metoclopramide ● Accelerate the sitivity to Drowsines reactions occur ● Check and
s intestinal treatment of metoclopr s, most frequently in verify
Brand name transit, gastroesoph amide. restlessnes children, young doctor’s
● Reglan promotes ageal reflux Concurre s, fatigue, adults (18–30 yrs) order
gastric disease nt use of lethargy. regarding
Usual Route emptying. (GERD), medicatio ● Arrhythmias, the
PO Relieves prevention ns likely Occasion medicatio
nausea, of nausea to al: ● Neuroleptic n.
Drug order: vomiting. and produce Dizziness, malignant ● Observe 10
● Metoclopramide vomiting, extrapyra anxiety, syndrome rights: Right
one tablet every 8 Action and to midal headache, (diaphoresis, patient, drug,
hours PRN for ● Blocks stimulate reactions. insomnia, fever, unstable dose, time, and
vomiting. dopamine/s gastric Suspected breast B/P, muscular route.
erotonin emptying. GI tenderness rigidity) has been ● Make a
UsualDosage/ receptors obstructio , altered reported. medication card
Frequency: in n, menstruati with the
10 mg q6h prn chemorece perforatio on, complete
ptor trigger n, or constipati doctor’s
zone of the hemorrha on, rash, order, name of the
CNS. ge dry patient, bed
Enhances mouth, number and
room/ward
 acetylcholi galactorrh ● Obtain and
ne ea, record vital
response in gynecoma signs.
upper GI stia ● Secure a copy of
tract, the client’s health
causing Rare: history for
increased Hypotension, contraindications
motility hypertension, and drug
and interactions
tachycardia
accelerated (notify the
gastric physician if any).
emptying ● Review the
without patient’s
stimulating history and
gastric, check for
allergies and
biliary, or
contraindicatio
pancreatic ns with the
secretions; medication.
increases ● Educate and
lower explain the
esophageal medication to
sphincter the client, how
tone it works, why it
is given to him,
Clinical: and the
GI agent, possible side
antiemetic. effects
● Assess for
PHARMACOKIN
dehydration
ETICS
(poor skin
Absorption:
turgor, dry
● Well mucous
 absorbed membranes,
from GI longitudinal
tract furrows in
tongue)
Protein binding ● Assess for
● 30%. nausea,
vomiting,
Distribution: abdominal
● Not distention,
Available bowel sounds.

Metabolism:
● Metabolized DURING
in liver ● Ask the
client’s full
Excretion: name to
verify his
● Primarily
identity.
excreted in
● Follow the
urine directions on
the medicine
label.
PHARMACODY ● Position
NAMICS: patient
appropriately
Onset for
● 30–60 min medication
administratio
Peak: n.
● N/A ● Ensure proper
body
Duration mechanics
● 1–2 hrs for the
healthcare
 providers
Half-life: ● Instruct the
● 4–6 hrs. patient how
to use the
inhalation
● Administer
Metoclopram
ide one tablet
every 8
hours PRN
for vomiting.

After:
● Monitor for
anxiety,
restlessness,
extrapyramidal
symptoms (EPS)
during IV
administration.
● Monitor daily
pattern of bowel
activity, stool
consistency.
● Monitor daily
pattern of bowel
activity, stool
consistency.
Assess skin for
rash.
● Evaluate for
therapeutic
response from
gastroparesis
 (nausea,
vomiting,
bloating).
● Monitor renal
function, B/P,
heart rate.
● Educate the
patient to avoid
tasks that
require
alertness, motor
skills until
response to drug
is established.
● Advise to report
involuntary eye,
facial, limb
movement
(extrapyramidal
reaction).
● Document all
the relevant
information
such as name of
the drug, dosage
and time it was
given. Also, the
patient
condition.